Akorn Pharmaceuticals

Akorn Investor Relations

Press Releases

Date Title  
02/26/20 Akorn Provides Fourth Quarter and Full Year 2019 Results Printer Friendly Version
02/12/20 Akorn Announces New Extension of Standstill with Lenders and Agrees to Pursue a Sale of its Business Printer Friendly Version
02/10/20 Akorn Continues Negotiations with Lenders Printer Friendly Version